JPH03850B2 - - Google Patents

Info

Publication number
JPH03850B2
JPH03850B2 JP61133230A JP13323086A JPH03850B2 JP H03850 B2 JPH03850 B2 JP H03850B2 JP 61133230 A JP61133230 A JP 61133230A JP 13323086 A JP13323086 A JP 13323086A JP H03850 B2 JPH03850 B2 JP H03850B2
Authority
JP
Japan
Prior art keywords
sorbitol
substance
pharmaceutically acceptable
acceptable salt
sorbitol accumulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61133230A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62289594A (ja
Inventor
Kyoya Takahata
Fumiaki Yoshino
Fumio Hirose
Takami Fujii
Masanori Ubusawa
Tadaaki Kato
Chikao Yoshikumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP61133230A priority Critical patent/JPS62289594A/ja
Priority to BE8700625A priority patent/BE1004392A4/fr
Priority to DE19873719124 priority patent/DE3719124A1/de
Priority to AU74039/87A priority patent/AU581368B2/en
Publication of JPS62289594A publication Critical patent/JPS62289594A/ja
Publication of JPH03850B2 publication Critical patent/JPH03850B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP61133230A 1986-06-09 1986-06-09 アミノ安息香酸誘導体よりなるソルビト−ル蓄積阻害剤 Granted JPS62289594A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP61133230A JPS62289594A (ja) 1986-06-09 1986-06-09 アミノ安息香酸誘導体よりなるソルビト−ル蓄積阻害剤
BE8700625A BE1004392A4 (fr) 1986-06-09 1987-06-05 Agent derive de l'acide adinobenzoique anti-accumulation de sorbitol .
DE19873719124 DE3719124A1 (de) 1986-06-09 1987-06-06 Ein aminobenzoesaeurederivat enthaltendes mittel zum verhindern der anreicherung von sorbit in einem lebenden koerper
AU74039/87A AU581368B2 (en) 1986-06-09 1987-06-09 Agent for preventing the accumulation of sorbitol in a living body, which comprises a derivative of aminobenzoic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61133230A JPS62289594A (ja) 1986-06-09 1986-06-09 アミノ安息香酸誘導体よりなるソルビト−ル蓄積阻害剤

Publications (2)

Publication Number Publication Date
JPS62289594A JPS62289594A (ja) 1987-12-16
JPH03850B2 true JPH03850B2 (fr) 1991-01-09

Family

ID=15099766

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61133230A Granted JPS62289594A (ja) 1986-06-09 1986-06-09 アミノ安息香酸誘導体よりなるソルビト−ル蓄積阻害剤

Country Status (4)

Country Link
JP (1) JPS62289594A (fr)
AU (1) AU581368B2 (fr)
BE (1) BE1004392A4 (fr)
DE (1) DE3719124A1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5716898A (en) * 1980-07-03 1982-01-28 Kureha Chem Ind Co Ltd Prostaglandin controller containing aminobenzoic derivative
SE448602B (sv) * 1978-04-06 1987-03-09 Kureha Chemical Ind Co Ltd Medicinsk komposition innehallande ett derivat av ortoaminobensoesyra sasom aktiv bestandsdel
SE446299B (sv) * 1978-04-11 1986-09-01 Kureha Chemical Ind Co Ltd Medicinsk komposition innehallande ett derivat av para-aminobensoesyra som aktiv bestandsdel
JPS5924967B2 (ja) * 1981-07-27 1984-06-13 呉羽化学工業株式会社 アミノ安息香酸誘導体を含有する抗糖尿病剤
JPS57136519A (en) * 1982-01-19 1982-08-23 Kureha Chem Ind Co Ltd Antidiabetic containing aminobenzoic acid derivative
JPS5939408B2 (ja) * 1982-01-27 1984-09-22 呉羽化学工業株式会社 オルト又はメタアミノ安息香酸誘導体を含有する抗糖尿病剤
AU554396B2 (en) * 1982-12-03 1986-08-21 Kureha Kagaku Kogyo K.K. Pharmaceutical compositions of amino benzoic acid derivatives

Also Published As

Publication number Publication date
DE3719124C2 (fr) 1991-08-08
DE3719124A1 (de) 1987-12-10
BE1004392A4 (fr) 1992-11-17
AU581368B2 (en) 1989-02-16
AU7403987A (en) 1987-12-17
JPS62289594A (ja) 1987-12-16

Similar Documents

Publication Publication Date Title
JP5337040B2 (ja) Ｓｇｌｔ−２インヒビターとの組み合わせ治療及びそれらの医薬組成物
TW201040193A (en) Pharmaceutical composition, methods for treating and uses thereof
KR0149029B1 (ko) 지사제 조성물
US4372948A (en) Derivative of saccharide and physiologically active agent containing the same
CA3134800A1 (fr) Formulation de combinaison triple a faible dose
US20110112184A1 (en) Compounds with glycidic structure active in the therapy of systemic and local inflammation
DE2921328C3 (de) Arzneimittel zur Behandlung von Hyperglykämie, Hyperlipämie, Hypertension, von inflammatorischen Erkrankungen, Schmerzen, Pyrexie und Tumoren
DE2914493A1 (de) Pharmazeutisches praeparat mit einem para-aminobenzoesaeurederivat als wirkstoff
JPH03850B2 (fr)
DE2914005C2 (de) Arzneimittel zur Behandlung von Hyperglykämie, Hyperlipämie, Hypertension, inflammatorischen Erkrankungen, Schmerzen und Pyrexie durch Erregung des Zentralnervensystems und von Tumoren
EP0154523B1 (fr) Produit pharmaceutique contenant de l'azapropazone
US4315921A (en) Pharmaceutical composition containing fara-amino-benzoic acid-N-D-xyloside as an active ingredient
US4380536A (en) Pharmaceutical composition containing para-amino-benzoic acid-N-D-mannoside as an active ingredient
US4450156A (en) Pharmaceutical composition containing a derivative of ortho-aminobenzoic acid as an active ingredient
JP2019507121A (ja) 下剤組成物
US4313939A (en) Pharmaceutical composition containing para-aminobenzoic acid-N-L-rhamnoside as an active ingredient
US4322408A (en) Pharmaceutical composition containing a derivative of para-aminobenzoic acid as an active ingredient
JP3631510B2 (ja) 細菌バイオフィルム形成阻害剤
JPH0142926B2 (fr)
JPS6254772B2 (fr)
US20220175931A1 (en) Osmotic pressure regulator for peritoneal dialysate containing d-allose and/or d-allulose
JPS6041079B2 (ja) オルト又はメタアミノ安息香酸誘導体
CA1161363A (fr) Compose pharmaceutique contenant un derive de l'acide ortho-aminobenzoique comme ingredient actif
DE3048279A1 (de) Aminobenzoesaeurederivate und deren verwendung
JP5652963B2 (ja) 腹膜肥厚抑制剤